Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

CGON CG Oncology Inc

17,63

-0,15 (-0,84%)

10 Apr 2025 - Geschlossen

Verzögert um 15 Minuten

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

08/29/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Hong Fang Song, Simone

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

CG Oncology (NASDAQ:CGON)
Historical Stock Chart
Von Mär 2025 bis Apr 2025

Click Here for more CG Oncology Charts.

CG Oncology (NASDAQ:CGON)
Historical Stock Chart
Von Apr 2024 bis Apr 2025

Click Here for more CG Oncology Charts.

News CG Oncology Inc

CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates
Montag 31 März 2025 (2 Wochen vor) • GlobeNewswire Inc.

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
Freitag 28 März 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Freitag 28 März 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 28 März 2025 (2 Wochen vor) • Edgar (US Regulatory)

CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates
Freitag 28 März 2025 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 24 März 2025 (3 Wochen vor) • Edgar (US Regulatory)

Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
Montag 24 März 2025 (3 Wochen vor) • GlobeNewswire Inc.

CG Oncology to Participate in the 40th Annual European Association of Urology Congress with a Series of Key Presentations and Updates
Mittwoch 12 März 2025 (4 Wochen vor) • GlobeNewswire Inc.

CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference
Mittwoch 26 Februar 2025 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 10 Januar 2025 (3 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 18 Dezember 2024 (4 Monate vor) • Edgar (US Regulatory)

CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Montag 16 Dezember 2024 (4 Monate vor) • GlobeNewswire Inc.

Weitere CG Oncology Inc News-Artikel

Energy Select Sector SPDR

BNP Paribas (QX)

JP Morgan Chase

Deutsche Lufthansa

Gold vs US Dollar

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen